ÂÜÀòÂÒÂ×

Yves Dubaquie has extensive work experience in the field of diagnostics and pharmaceuticals. Yves is currently working at Revvity as SVP Diagnostics since May 2023. Prior to that, they held the same role at PerkinElmer, Inc. from April 2022 to May 2023. Before that, they were SVP, Head of Diagnostics Solutions at MilliporeSigma from August 2019 to April 2022. Additionally, they served as the Global Head of Business Development at MilliporeSigma from January 2017 to July 2019. Yves also has experience in business development and licensing at Novartis Molecular Diagnostics from August 2009 to August 2012. Earlier in their career, they held various roles in business development at Ironwood Pharmaceuticals, Bristol-Myers Squibb Medical Imaging, and Bristol-Myers Squibb Pharmaceuticals. Yves started their career as a Postdoctoral Fellow at Genentech.

Yves Dubaquie obtained a Ph.D. in Biochemistry from the University of Basel from 1993 to 1997. Prior to that, they completed their Masters in Natural Sciences at ETH Zürich from 1988 to 1993. Yves Dubaquie also holds a Ph.D. certification from Universität Basel.